Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Miltenyi Biotec GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10304
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulation, cell therapy, cell manufacturing, therapeutic apheresis, molecular and imaging products. Its cell separation products comprise cell separation reagents, cell separation instruments, columns, separators, and buffers and solutions. Miltenyi also offers instrument services, technical support, ordering and delivery and customized application services. The company operates in Germany, the US, the UK, France, Italy, Singapore, Japan, South Korea and others. Miltenyi is headquartered in Bergisch Gladbach, Germany.

Miltenyi Biotec GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miltenyi Biotec GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Miltenyi Biotec GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Miltenyi Biotec GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Miltenyi Biotec GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Miltenyi Biotec GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Miltenyi Biotec GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Cellenion and Miltenyi Biotec Enter into Co-Marketing Agreement 10
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 11
Miltenyi Biotec Enters Into Distribution Agreement With Tree Star 12
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 13
Acquisition 14
Miltenyi Biotec Acquires LaVision BioTec 14
Miltenyi Biotec Acquires Sensovation 15
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 16
Miltenyi Biotec GmbH – Key Competitors 17
Miltenyi Biotec GmbH – Key Employees 18
Miltenyi Biotec GmbH – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Miltenyi Biotec GmbH, Medical Equipment, Key Facts 2
Miltenyi Biotec GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Miltenyi Biotec GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Miltenyi Biotec GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Miltenyi Biotec GmbH, Deals By Market, 2012 to YTD 2018 8
Miltenyi Biotec GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cellenion and Miltenyi Biotec Enter into Co-Marketing Agreement 10
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 11
Miltenyi Biotec Enters Into Distribution Agreement With Tree Star 12
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 13
Miltenyi Biotec Acquires LaVision BioTec 14
Miltenyi Biotec Acquires Sensovation 15
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 16
Miltenyi Biotec GmbH, Key Competitors 17
Miltenyi Biotec GmbH, Key Employees 18
Miltenyi Biotec GmbH, Other Locations 19
Miltenyi Biotec GmbH, Subsidiaries 19

List of Figures
Miltenyi Biotec GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Miltenyi Biotec GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Miltenyi Biotec GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Miltenyi Biotec GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sprouts Farmers Markets, Inc (SFM):企業の財務・戦略的SWOT分析
    Sprouts Farmers Markets, Inc (SFM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • GEN energija, d.o.o.:企業の戦略的SWOT分析
    GEN energija, d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CA, Inc.:企業のM&A・事業提携・投資動向
    CA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CA, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Premier Marketing Public Company Limited:戦略・SWOT・企業財務分析
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • AMERCO:企業の戦略・SWOT・財務情報
    AMERCO - Strategy, SWOT and Corporate Finance Report Summary AMERCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Honeywell International Inc.:企業の戦略・SWOT・財務情報
    Honeywell International Inc. - Strategy, SWOT and Corporate Finance Report Summary Honeywell International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AGF Management Limited:企業の戦略・SWOT・財務情報
    AGF Management Limited - Strategy, SWOT and Corporate Finance Report Summary AGF Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AcelRx Pharmaceuticals Inc (ACRX):医療機器:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …
  • China Aerospace Science and Technology Corporation:企業の戦略・SWOT・財務情報
    China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Fluidigm Corp (FLDM)-医療機器分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Biocon Ltd (BIOCON):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and …
  • JK Sucralose Inc.:企業の戦略・SWOT・財務情報
    JK Sucralose Inc. - Strategy, SWOT and Corporate Finance Report Summary JK Sucralose Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Akenerji Elektrik Uretim AS (AKENR):企業の財務・戦略的SWOT分析
    Akenerji Elektrik Uretim AS (AKENR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sempra Energy:企業の戦略・SWOT・財務分析
    Sempra Energy - Strategy, SWOT and Corporate Finance Report Summary Sempra Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Chemring Energetics UK Ltd:企業の戦略・SWOT・財務情報
    Chemring Energetics UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Chemring Energetics UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Toll Brothers, Inc.:企業の戦略・SWOT・財務情報
    Toll Brothers, Inc. - Strategy, SWOT and Corporate Finance Report Summary Toll Brothers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ToolGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • Legrand SA:企業の戦略・SWOT・財務情報
    Legrand SA - Strategy, SWOT and Corporate Finance Report Summary Legrand SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lattice Semiconductor Corp (LSCC):企業の財務・戦略的SWOT分析
    Lattice Semiconductor Corp (LSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Brunswick Corporation (BC):企業の財務・戦略的SWOT分析
    Brunswick Corporation (BC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆